PYC Therapeutics Ltd Market Cap ($794.49 Million)

$794.49 Million USD · AU$1.12 Billion AUD · Rank #9547

Market Cap & Net Worth: PYC Therapeutics Ltd (PYC)

PYC Therapeutics Ltd market cap. PYC Therapeutics Ltd (AU:PYC) has a market capitalization of $794.49 Million (AU$1.12 Billion) as of November 1, 2026. Listed on the AU stock exchange, this Australia-based company holds position #9547 globally and #236 in its home market, demonstrating a 3.87% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying PYC Therapeutics Ltd's stock price AU$1.88 by its total outstanding shares 597258697 (597.26 Million). Also see PYC Therapeutics Ltd (PYC) cash flow conversion for how efficiently the company converts equity into cash flow.

PYC Therapeutics Ltd Market Cap History (2015–2026)

PYC Therapeutics Ltd market cap history from 2015 to 2026. Data shows growth from $53.08 Million to $794.49 Million (27.78% CAGR). Check PYC stock price and chart for real-time trading data and today's change.

Index Memberships

PYC Therapeutics Ltd is a constituent of 1 market index:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
Australia All Ordinaries AORD	$2.01 Trillion	0.04%	#187 of 495

Weight: PYC Therapeutics Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

PYC Therapeutics Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how PYC Therapeutics Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore PYC net asset momentum to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

29.77x

PYC Therapeutics Ltd's market cap is 29.77 times its annual revenue

Industry average: 3868.91x Lower than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$97.96 Million	$1.08K	-$3.98 Million	91039.36x	N/A
2017	$163.29 Million	$2.76 Million	-$1.95 Million	59.11x	N/A
2018	$114.27 Million	$48.46K	-$7.43 Million	2358.04x	N/A
2019	$257.19 Million	$250.00	-$4.08 Million	1028773.98x	N/A
2020	$615.98 Million	$2.40 Million	-$6.82 Million	257.12x	N/A
2021	$563.79 Million	$3.07 Million	-$17.77 Million	183.38x	N/A
2022	$288.17 Million	$16.04 Million	-$13.86 Million	17.96x	N/A
2023	$459.41 Million	$15.81 Million	-$22.79 Million	29.06x	N/A
2024	$557.83 Million	$22.06 Million	-$37.73 Million	25.29x	N/A
2025	$699.40 Million	$23.49 Million	-$50.30 Million	29.77x	N/A

Competitor Companies of PYC by Market Capitalization

Companies near PYC Therapeutics Ltd in the global market cap rankings as of November 1, 2026. Also see PYC Therapeutics Ltd balance sheet assets for a full breakdown of the balance sheet.

Key companies related to PYC Therapeutics Ltd by market ranking:

Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#182	Vertex Pharmaceuticals Inc	NASDAQ:VRTX	$130.90 Billion	$558.88
#371	Regeneron Pharmaceuticals Inc	NASDAQ:REGN	$76.14 Billion	$927.89
#412	CSL Ltd	AU:CSL	$68.91 Billion	AU$200.73
#495	Moderna Inc	NASDAQ:MRNA	$54.14 Billion	$221.72

Market Capitalization of PYC Therapeutics Ltd (2015–2026)

Market capitalization of PYC Therapeutics Ltd from 2015 to today. Between 2015 and today, PYC Therapeutics Ltd's market cap moved from $53.08 Million to $ 794.49 Million, with a yearly change of 27.78%.

Year	Market Cap	Change (%)
2026	AU$794.49 Million	+13.60%
2025	AU$699.40 Million	+25.38%
2024	AU$557.83 Million	+21.42%
2023	AU$459.41 Million	+59.42%
2022	AU$288.17 Million	-48.89%
2021	AU$563.79 Million	-8.47%
2020	AU$615.98 Million	+139.50%
2019	AU$257.19 Million	+125.07%
2018	AU$114.27 Million	-30.02%
2017	AU$163.29 Million	+66.70%
2016	AU$97.96 Million	+84.55%
2015	AU$53.08 Million	--

End of Day Market Cap According to Different Sources

On Oct 31st, 2026 the market cap of PYC Therapeutics Ltd was reported to be:

Source	Market Cap
Yahoo Finance	$794.49 Million USD
MoneyControl	$794.49 Million USD
MarketWatch	$794.49 Million USD
marketcap.company	$794.49 Million USD
Reuters	$794.49 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About PYC Therapeutics Ltd

AU:PYC Australia Biotechnology

Market Cap

$794.49 Million

AU$1.12 Billion AUD

Market Cap Rank

#9547 Global

#236 in Australia

Share Price

AU$1.88

Change (1 day)

-2.84%

52-Week Range

AU$1.07 - AU$2.91

All Time High

AU$2.91